image-media-type
false
true
Primary Containers
We connect primary container technologies and prefillable syringe expertise to support the protection, compatibility, and delivery of injectable drug products
Through our PLAJEX™ ready-to-fill (RTF) polymer syringes and broader primary container capabilities, Terumo Pharmaceutical Solutions Division supports pharmaceutical and biotechnology companies across a range of injectable drug applications.
media-bottom
true
image-media-type
media-top
true
pd-y-64
PLATFORM ROLE
Connecting Primary Containers to the Patient
Within the Deviceuticals™ framework, the Primary Container platform brings ready-to-fill polymer syringe technologies and containment expertise focused on the protection, compatibility and delivery of injectable drug products.
Together with the injectable drug delivery technologies of Injection Devices and the development, fill-finish and assembly capabilities of CDMO Services, Primary Containers can connect containment expertise with broader drug delivery and development capabilities across a wide range of applications.
image-media-type
media-left
true
pd-y-64
PLATFORM CAPABILITIES
Explore our Advancing Prefillable Polymer Syringe Technologies
media-top
true
- Polymer barrel construction
PLAJEX ™ ready-to-fill syringes feature injection-molded cyclic olefin polymer (COP) barrels, providing strength and clarity1, with tungsten-free construction resulting in lower extractables1. - Range of configurations
Needle-integrated configurations include Staked (straight) needle and Tapered needle options alongside needle-free Luer Lock configurations. PLAJEX™ needle-integrated systems are manufactured without adhesives using laser welding or insert molding. - Propriety i-coating™ Stopper Coating Technology
Tailored to address unique drug product requirements, PLAJEX™ syringe systems feature Terumo’s optional propriety i-coating™ stopper technology2, providing consistent and predictable gliding force while eliminating the need for silicone oil. The silicone oil-free syringe systems are designed to preserve sensitive biotherapeutics1. - Ready-to-fill (RTF) design
Pre-sterilized using steam sterilization, PLAJEX ready-to-fill syringes are configured for efficient filling and packaging.
normal
variation-1
cards-3
variation-1-card
image
PLAJEX™ 0.5mL Luer Lock Silicone Oil-free Syringes
Specifically optimized for patient safety and comfort in low dose applications such as Ophthalmic injections, PLAJEX™ 0.5mL Luer Lock Silicone Oil-Free Syringes feature Terumo’s propriety i-coating™ stopper technology to avoid formation of silicone oil droplets in the eyes2.
Explore PLAJEX™ 0.5mL Luer Lock Silicone Oil-free Syringes
variation-1-card
image
PLAJEX™ Ready-to-Fill Polymer Syringes with Luer Lock
Designed for all Luer applications, PLAJEX™ Ready-to-Fill Polymer Syringes with Luer Lock come nested and sterilized, ready for filling and finishing
Explore PLAJEX™ Ready-to-Fill Polymer Syringes with Luer Lock
variation-1-card
image
PLAJEX™ Ready-to-Fill Polymer Syringes with Tapered Needle
PLAJEX™ Ready-to-Fill Polymer Syringes Tapered Needle are designed for patient comfort and quality, providing improved injectability for highly viscous or concentrated formulations4.
Explore PLAJEX™ Ready-to-Fill Polymer Syringes with Tapered Needle
variation-1-card
image
PLAJEX™ Ready-to-Fill Polymer Syringes with Staked Needle
Integrating a Staked (straight) Needle with robust silicone oil-free polymer syringe, PLAJEX™ Ready-to-Fill Polymer Syringe with Staked Needle is designed to preserve senstive biotherapeutics.
Explore PLAJEX™ Ready-to-Fill Polymer Syringes with Staked Needle
pd-y-64
pd-y-64
APPLICATIONS
Matching Device Expertise with Therapeutic Context
Primary container requirements vary according to the therapy and administration route. Explore a range of applications to identify relevant drug delivery technologies and expertise that support specific injectable drug delivery needs.
media-top
true
variation-2
cards-4
variation-2-card
nothing
TBD
Biologics
Learn More
Learn More
variation-2-card
nothing
TBD
Ophthalmics
Learn More
Learn More
variation-2-card
nothing
TBD
Central Nervous System Disorders
Learn More
Learn More
variation-2-card
nothing
TBD
Aesthetics
Learn More
Learn More
pd-y-64
INSIGHTS AND RESOURCES
Insights into Injectable Drug Delivery
Access the latest insights into injectable drug delivery, administration and device technologies through our whitepapers and technical resources.
media-top
true
variation-1
cards-2
variation-1-card
image
Preparing parenteral packaging for the next generation of complex therapies
Kimiya Mori | Product Specialist | Terumo Pharmaceutical Solutions Division
Published on PDA Parenteral Packaging Supplement 2026
Read the full article
pd-y-64
pd-y-64
CONNECTED THROUGH DEVICEUTICALS™
One Platform within a Connected Drug Delivery Journey
Primary Containers is one of three complementary platforms connected through the Deviceuticals™ framework. With a focus on protection, compatibility and delivery of injectable drug products, Primary Container platform brings technologies and expertise that complement the drug delivery and administration of Injection Devices and the formulation, fill-finish and assembly capabilities of CDMO Services. Together these connected capabilities support a more integrated approach, enabling earlier collaboration and a smoother journey from molecule to patient.
Explore Deviceuticals™
image-media-type
media-left
true
FREQUENTLY ASKED QUESTIONS
Injection Device Platform FAQs
media-top
true
side-image
What is the Injection Device Platform?
The Injection Device platform brings together injectable drug delivery technologies and device expertise focused on the delivery and administration of injectable therapies. Its capabilities span drug delivery devices, injection needles, safety needles, disposable syringes and infusion sets, supporting a range of administration and application needs.
How does the Injection Device Platform fit within the Deviceuticals™ Framework?
Injection Devices is one of three complementary Deviceuticals™ platforms, alongside Primary Containers and CDMO Services. Injection Devices focuses on drug delivery and administration, while the broader Deviceuticals™ framework connects capabilities across containment, delivery, development and manufacturing to support a more integrated path from molecule to patient.
How does the Injection Devices platform connect with Primary Containers?
Primary containers and delivery technologies play interconnected roles in injectable therapy development. Through the Deviceuticals™ framework, Injection Devices capabilities can connect with Primary Containers expertise to bring delivery, administration, compatibility and containment considerations into a more connected approach.
How does the Injection Device platform connect with CDMO Services?
Within the Deviceuticals™ framework, Injection Devices brings a delivery and administration perspective that can connect with CDMO Services capabilities across formulation development, fill-finish, device assembly and packaging. Bringing these capabilities together can support closer consideration of device requirements across development and commercialisation.
Which injectable drug delivery technologies does Terumo Pharmaceutical Solutions Division offer?
Terumo Pharmaceutical Solutions Division offers capabilities across drug delivery devices, injection needles, safety needles, disposable syringes and infusion sets. These technologies support different injectable drug delivery applications and administration needs.
DISCUSS YOUR PROJECT
Explore the right device pathway for your injectable therapy
Connect with Terumo Pharmaceutical Solutions experts to discuss how our Injection Device platform capabilities can support your latest injectable drug delivery applications or project needs.
Connect with our Experts
Explore Deviceuticals™
media-top
true
pd-y-64